文献速递神经儿科影像MR

氨己烯酸相关脑部异常的MRI表现及其鉴别诊断

The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis.
PubMed 文献 · Clin Radiol · 2023-11-29

氨己烯酸是抑制γ-氨基丁酸转氨酶的抗癫痫药,用于婴儿痉挛症和难治性局灶性发作。使用氨己烯酸治疗婴儿痉挛症的儿童中22–32%出现MRI脑部异常,典型表现为双侧对称T2高信号伴弥散受限,常累及苍白球、丘脑、底丘脑核、大脑脚、中脑、脑干背侧(含内侧纵束)及小脑齿状核。本文综述其临床表现、组织病理学特征、影像学表现及鉴别诊断。

要点

  • 氨己烯酸相关脑部异常典型为双侧对称T2高信号伴弥散受限,常累及苍白球、丘脑、底丘脑核、大脑脚、中脑、脑干背侧及小脑齿状核。
  • 使用氨己烯酸治疗婴儿痉挛症的儿童中22–32%出现MRI脑部异常,临床通常无症状。
  • 危险因素包括隐源性婴儿痉挛症、年龄<12个月、高剂量及可能的合并激素治疗。

核心结论

  • 氨己烯酸相关脑部异常在MRI上表现为双侧对称T2高信号伴弥散受限,常累及苍白球、丘脑、底丘脑核、大脑脚、中脑、脑干背侧(含内侧纵束)及小脑齿状核,临床通常无症状,组织病理学显示白质空泡化和髓鞘内水肿。

研究设计与样本

  • 综述,回顾氨己烯酸相关脑部异常的临床表现、组织病理学特征、影像学表现及鉴别诊断。

关键影像表现/征象

  • MRI典型表现为双侧对称T2加权成像高信号,伴弥散受限。
  • 常累及苍白球、丘脑、底丘脑核、大脑脚、中脑、脑干背侧(包括内侧纵束)及小脑齿状核。

诊断标准与关键数值

  • 使用氨己烯酸治疗婴儿痉挛症的儿童中,MRI脑部异常的发生率为22–32%。
  • 使用氨己烯酸1年后,高达30%的患者出现视网膜毒性。
  • 危险因素包括隐源性婴儿痉挛症、年龄<12个月、高剂量及可能的合并激素治疗。

临床应用与阅片要点

  • 识别双侧对称T2高信号伴弥散受限的分布模式(苍白球、丘脑、底丘脑核、大脑脚、中脑、脑干背侧及小脑齿状核)有助于提示氨己烯酸相关脑部异常。
  • 临床通常无症状,影像异常需结合氨己烯酸用药史判断。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Vigabatrin is an anti-epileptic drug that inhibits the enzyme γ-aminobutyric acid (GABA)-transaminase. The anticonvulsant effect of vigabatrin involves increasing GABA levels and attenuating glutamate-glutamine cycling. Vigabatrin indications include infantile spasms and refractory focal seizures. Despite having a significant role in paediatric epileptology, vigabatrin has adverse effects, such as retinal toxicity, in up to 30% of patients after 1 year of use and brain abnormalities on magnetic resonance imaging (MRI). The percentage of patients with brain abnormalities on MRI varies between 22-32% of children using vigabatrin to treat infantile spasms. Risk factors for presenting these imaging abnormalities are cryptogenic infantile spasms, age <12 months old, high dosage, and possible concomitant hormonal therapy. Clinically, these abnormalities are usually asymptomatic. Histopathological analysis reveals white matter vacuolation and intramyelinic oedema. The typical findings of vigabatrin-associated brain abnormalities on MRI are bilateral and have a symmetrical hyperintense signal on T2-weighted imaging, with diffusion restriction, that often compromise the globi pallidi, thalami, subthalamic nuclei, cerebral peduncles, midbrain, dorsal brainstem, including the medial longitudinal fasciculi, and dentate nuclei of the cerebellum. In this article, the authors intend to review the clinical manifestations, histopathological features, imaging aspects, and differential diagnosis of vigabatrin-associated brain abnormalities on MRI.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Corrêa DG, Telles B, Freddi TAL, et al. The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis. Clin Radiol. 2023. PMID: 38092645. doi:10.1016/j.crad.2023.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。